Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ALFACELL CORP | 400,000 | reported | 23 Jul 2012 | tx 8+800,000 |
| LAURIER INTERNATIONAL INC | 223,445 | reported | 24 Feb 2014 | tx 1+223,445 |
| NEOPHARM INC | 25,000 | reported | 25 Jan 2006 | tx 2+45,000 |
| PAR PHARMACEUTICAL COMPANIES, INC. | 14,337 | reported | 02 Aug 2010 | tx 27+172,049−50,087 |
| Oncobiologics, Inc. | 5,946 | reported | 26 Sept 2024 | tx 15+6,187,919−38,965 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 26 Sept 2024 | PURCHASE | Oncobiologics, Inc. | 5,000 | 5.69 USD | first after silence |
| 20 Mar 2024 | GRANT_AWARD | Oncobiologics, Inc. | 12,500 | 0.00 USD | deriv |
| 20 Apr 2021 | PURCHASE | Oncobiologics, Inc. | 10,000 | 1.83 USD | first after silence |
| 01 Oct 2020 | GRANT_AWARD | Oncobiologics, Inc. | 3,668,984 | 0.00 USD | deriv |
| 17 Jul 2020 | GRANT_AWARD | Oncobiologics, Inc. | 450,000 | 0.00 USD | deriv |
| 19 Mar 2020 | GRANT_AWARD | Oncobiologics, Inc. | 216,435 | 0.00 USD | deriv |
| 18 Sept 2019 | SALE | Oncobiologics, Inc. | 1,350 | 1.70 USD | |
| 12 Sept 2019 | GRANT_AWARD | Oncobiologics, Inc. | 450,000 | 0.00 USD | deriv |
| 19 Feb 2019 | GRANT_AWARD | Oncobiologics, Inc. | 800,000 | 0.00 USD | deriv |
| 07 Feb 2019 | PURCHASE | Oncobiologics, Inc. | 25,000 | 0.90 USD | first after silence |
| 18 Sept 2018 | SALE | Oncobiologics, Inc. | 10,100 | 0.87 USD | |
| 01 Aug 2018 | GRANT_AWARD | Oncobiologics, Inc. | 500,000 | 0.00 USD | deriv |
| 22 Dec 2017 | SALE | Oncobiologics, Inc. | 26,165 | 1.13 USD | |
| 21 Dec 2016 | GRANT_AWARD | Oncobiologics, Inc. | 50,000 | 0.00 USD | |
| 24 Feb 2014 | GRANT_AWARD | LAURIER INTERNATIONAL INC | 223,445 | 0.00 USD | deriv |
| 23 Jul 2012 | GRANT_AWARD | ALFACELL CORP | 400,000 | 0.00 USD | deriv |
| 02 Aug 2010 | TAX_WITHHOLDING | PAR PHARMACEUTICAL COMPANIES, INC. | 6,312 | 26.90 USD | |
| 03 Mar 2010 | SALE | PAR PHARMACEUTICAL COMPANIES, INC. | 400 | 25.26 USD | |
| 03 Mar 2010 | SALE | PAR PHARMACEUTICAL COMPANIES, INC. | 100 | 25.21 USD | |
| 03 Mar 2010 | SALE | PAR PHARMACEUTICAL COMPANIES, INC. | 300 | 25.27 USD | |
| 03 Mar 2010 | EXERCISE | PAR PHARMACEUTICAL COMPANIES, INC. | 21,439 | 13.06 USD | |
| 03 Mar 2010 | SALE | PAR PHARMACEUTICAL COMPANIES, INC. | 3,261 | 25.19 USD | |
| 03 Mar 2010 | SALE | PAR PHARMACEUTICAL COMPANIES, INC. | 700 | 25.19 USD | |
| 03 Mar 2010 | SALE | PAR PHARMACEUTICAL COMPANIES, INC. | 4,711 | 25.19 USD | |
| 03 Mar 2010 | SALE | PAR PHARMACEUTICAL COMPANIES, INC. | 500 | 25.20 USD |
3 purchases reported after at least 12 months of silence — most recent on 26 Sept 2024.